Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Takeda’s passion and pursuit of potentially life-changing treatments for patients are deeply rooted in the company’s distinguished history in Japan since 1781. Takeda has a presence in approximately 80 countries, delivering highly innovative medicines and transformative care for patients around the world. In Norway, Takeda is based in Asker with around 245 employees.

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With its focus on preventing, alleviating, and treating diseases and providing a reliable supply of high-quality food, feed, and plant-based raw materials, Bayer’s innovative products are contributing to finding solutions to some of the major challenges of our time – reflecting the company’s purpose, science for a better life. Bayer Norway is headquartered in Oslo and employs 155 people. Bayer’s vision is: Health for all, Hunger for none.

Sanofi has been leading pharmaceutical innovations for over 100 years. Globally, the company has more than 100,000 employees in over 100 countries and is headquartered in Paris, France. Sanofi is organized into three global business units, which all are represented in Norway: General Medicines, Specialty Care, and Vaccines. Sanofi-Aventis’ Norway branch is in Lysaker and employs 77 people.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Boehringer Ingelheim develops breakthrough therapies that improve the lives of humans and animals. As a research-driven biopharmaceutical leader, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 50,000 employees serve more than 130 markets in the three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In Norway, Boehringer Ingelheim employs 64 people. In 2021, Boehringer Ingelheim’s Norwegian Branch achieved a total net sales revenue of NOK 483,9 million.

As pioneers in neuroscience, Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Sir Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today, Biogen has a leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, and provides the first and only approved treatment to address a defining pathology of Alzheimer’s disease. Biogen also commercializes biosimilars and focuses on advancing the industry’s most diversified pipeline in neuroscience that will transform the standard of care for patients in several areas of high unmet need.

GSK’s purpose is to unite science, talent and technology to get ahead of disease together. Our research and development focus is to deliver new vaccines and medicines using the science of the immune system, human genetics and advanced technologies. This focus enables us to get ahead of infectious diseases, HIV, cancer and immune-mediated and respiratory diseases. Our large portfolio of vaccines helps protect people at all stages of life. In Norway, GSK has around 60  employees, with a turnover of about NOK 700 million. Haleon (GSK Consumer Healthcare until July 2022) will be a global leader 100% focused on consumer health.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. The company offers innovative treatments in a broad range of therapeutic areas. Novartis uses innovative science and technology to address some of society’s most challenging healthcare issues. Novartis discovers and develops breakthrough treatments and finds new ways to deliver them to as many people as possible. Novartis Norway is located in Nydalen and has around 110 employees.